Could you begin by giving a short introduction to Nordic Drugs and its current position within the structure of owner Nordic Group? Nordic Drugs started as…
In Conversation
As the blockbuster sales model fades, the rush is on for a new formula for growth, termed ‘Good growth’ by Pharmaceutical Executive: niched, balanced & sustainable…
“ Mr. O’Sullivan, can you please begin with a brief introduction to the Genzyme Waterford site? ”
“ Mr. O’Sullivan, can you please begin with a brief introduction to the Genzyme Waterford site? ”
“ Fergal Murphy, Chairman of the Association of Pharmaceutical Manufacturers in Ireland, discusses with pharamaboardroom.com the difficulties in such a small market and how the industry is… ”
Could you outline the significance of Denmark to IBM’s global operations? Industry in Denmark works with government on a basis of trust rather than mistrust. That…
You refer to AstraZeneca as the locomotive of bioscience in Sweden. Can you elaborate on what you mean by that, and the role that you see…
Last year, Boston Scientific took important steps to stabilise and strengthen its core businesses. Could you develop on the development trajectory of Boston Scientific in the…
There seems to be quite a hype around the Nordic region at the moment. How do you explain this phenomenon? I think that the Nordic region…
“ Mary Di Marzio has been General Manager of Nordics for Shire Inc for nearly 2 years now. Today she shares with Pharmaboardroom the progress of Shire’s… ”
An exclusive interview with the CEO of Novo Nordisk in the year of the company's 90th anniversary. During the interview, Sørensen discusses his time as CEO…
